This chapter of the formulary is populated with formulary dressings only. If a dressing is not listed it should be considered non-formulary.
The roll-out of a non-prescription dressings supply service is complete in Crawley, Horsham and Mid-Sussex. (excluding some of the nursing homes)
Details...
A5.01
Basic wound contact dressings
A5.01.01
Low adherence dressings
A5.01.02
Absorbent dressings
A5.01.02
For lightly exuding wounds
A5.01.02
For moderately to heavily exuding wounds
A5.01.02
For heavily exuding wounds
A5.02
Advanced wound dressings
A5.02.01
Hydrogel dressings
A5.02.01
Hydrogel application (amorphous)
A5.02.01
Hydrogel sheet dressings
A5.02.01.01
Sodium hyaluronate dressings
A5.02.02
Vapour-permeable films and membranes
A5.02.02
Vapour-permeable Adhesive Film Dressing (Semi-permeable Adhesive Dressing)
A5.02.02
Vapour-permeable Adhesive Film Dressing with absorbent pad
A5.02.02
For intravenous and subcutaneous catheter sites
A5.02.03
Soft polymer dressings
A5.02.03
Without absorbent pad
A5.02.03
With absorbent pad
A5.02.03
Bio-cellulose dressings
A5.02.04
Hydrocolloid dressings
A5.02.04
Without adhesive border
A5.02.04
With adhesive border
A5.02.04
Hydrocolloid-fibrous dressings
A5.02.04
Polyurethane matrix dressing
A5.02.05
Foam dressings
A5.02.05
For lightly exuding wounds
A5.02.05
For lightly to moderately exuding wounds
A5.02.05
For moderately to heavily exuding wounds
A5.02.06
Alginate dressings
A5.02.07
Capillary-action dressings
A5.02.08
Odour absorbent dressings
A5.03
Antimicrobial dressings
A5.03.01
Honey
A5.03.01
Sheet dressing
A5.03.01
Honey-based topical application
A5.03.02
Iodine
A5.03.03
Silver
A5.03.03
Low adherence dressings
A5.03.03
With charcoal
A5.03.03
Soft polymer dressings
A5.03.03
Hydrocolloid dressings
A5.03.03
Foam dressings
A5.03.03
Alginate dressings
A5.03.04
Other antimicrobials
A5.04
Specialised dressings
A5.04.01
Protease-modulating matrix dressings
A5.04.02
Silicone keloid dressings
A5.04.02
Silicone sheets
A5.04.02
Silicone gel
A5.05
Adjunct dressings and appliances
A5.05.01
Gauze and tissue
A5.05.01
Surgical absorbents
A5.05.01
Cotton
A5.05.01
Lint
A5.05.01
Pads
A5.05.02
Wound drainage pouches
A5.06
Complex adjunct therapies
A5.06.01
Topical negative pressure therapy
A5.06.01
Vacuum assisted closure products
A5.06.01
Wound drainage collection devices
A5.06.01
Accessories
A5.07
Wound care accessories
A5.07.01
Dressing packs
A5.07.02
Woven and fabric swabs
A5.07.03
Surgical adhesive tapes
A5.07.03
Permeable adhesive tapes
A5.07.03
Occlusive adhesive tapes
A5.07.04
Adhesive dressings
A5.07.04
Vapour permeable adhesive dressings
A5.07.05
Skin closure dressings
A5.07.05
Skin closure strips, sterile
A5.08
Bandages
A5.08.01
Non-extensible bandages
A5.08.02
Light-weight conforming bandages
A5.08.03
Tubular bandages and garments
A5.08.03
Elasticated
A5.08.03
Non-elasticated
A5.08.03
Silk Clothing
A5.08.04
Support bandages
A5.08.05
Adhesive bandages
A5.08.06
Cohesive bandages
A5.08.06
Cohesive extensible bandages
A5.08.07
Compression bandages
COMPRESSION(only health care staff who have undergone the specific training should apply compression bandaging.)
A5.08.07
High compression bandage
A5.08.07
Short stretch compression bandage
A5.08.07
Sub-compression wadding bandage
A5.08.08
Multi-layer compression bandaging
A5.08.08
Four layer systems
A5.08.08
Two layer systems
A5.08.09
Medicated bandages
A5.08.09
Medicated stocking
A5.09
Compression hosiery and garments
A5.09.01
Graduated compression hosiery
A5.09.01
Accessories
A5.09.01
Suspender
A5.09.01
Anklets
A5.09.01
Knee caps
A5.09.02
Lymphoedema garments
A5.10
Skin Protection
A5.11
Appliances
....
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
CCG
Traffic Light Status Information
Status
Description
Comment : Not to be routinely commissioned (prescribed) in any care setting (primary or secondary care).
This may be due to a lack of good clinical evidence, cost effectiveness, concerns over safety or due to the availability of more suitable alternatives. As such, drugs classified as Black should be considered as non-formulary.
Initiation : Specialist only Repeat Prescribing : Specialist Monitoring : Specialist Comment : Prescribing must be in line with any specific treatment criteria outlined. In exceptional circumstances a GP may be asked to prescribe – the specialist must provide adequate information and support.
Initiation : Specialist only
Repeat Prescribing : Primary care OR specialist
Monitoring : Primary care OR specialist
Comment : Monitoring according to Effective Shared Care Agreement (ESCA) for stabilised patients only. GP agreement should be requested by specialist and confirmed/declined by GP on a patient-by-patient basis.
Initiation/Recommendation : Specialist only Repeat Prescribing : Primary care Monitoring : Primary care Comment : Should be initiated or recommended by a specialist. Monitoring of either medicine or disease does not require specialist skills or equipment
Initiation : Primary care or specialist
Repeat Prescribing : Primary care
Monitoring : Primary care
Comment : Suitable for non specialist initiation
Patients should be advised to purchase if approriate.